• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Operating Officer Lesueur Daniel sold $21,604 worth of shares (5,209 units at $4.15), decreasing direct ownership by 2% to 211,041 units (SEC Form 4)

    4/7/25 7:02:12 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology
    Get the next $HCAT alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    X
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    LeSueur Daniel

    (Last) (First) (Middle)
    C/O HEALTH CATALYST, INC.
    10897 S. RIVER FRONT PARKWAY, #300

    (Street)
    SOUTH JORDAN UT 84095

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Health Catalyst, Inc. [ HCAT ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Operating Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    04/03/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 04/03/2025 S(1) 5,209 D $4.1475 211,041 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 7, 2024 in accordance with Rule 10b5-1.
    Remarks:
    /s/ Benjamin Landry, as Attorney-in-Fact 04/07/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $HCAT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HCAT

    DatePrice TargetRatingAnalyst
    4/9/2025Outperform → In-line
    Evercore ISI
    1/8/2025$9.00Sector Weight → Overweight
    KeyBanc Capital Markets
    4/10/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    1/3/2024$14.00Overweight
    Barclays
    1/3/2024$11.00In-line → Outperform
    Evercore ISI
    12/13/2023$14.00 → $11.00Neutral → Overweight
    JP Morgan
    11/13/2023$12.00 → $11.00Neutral → Overweight
    Piper Sandler
    8/1/2023$16.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $HCAT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Burton Daniel D. bought $204,525 worth of shares (26,200 units at $7.81), increasing direct ownership by 2% to 1,172,623 units (SEC Form 4)

      4 - Health Catalyst, Inc. (0001636422) (Issuer)

      2/27/24 4:01:39 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology

    $HCAT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

      SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

      11/14/24 7:51:57 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • SEC Form SC 13G filed by Health Catalyst Inc

      SC 13G - Health Catalyst, Inc. (0001636422) (Subject)

      11/14/24 4:44:34 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

      SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

      11/12/24 3:55:05 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology

    $HCAT
    SEC Filings

    See more
    • SEC Form 10-Q filed by Health Catalyst Inc

      10-Q - Health Catalyst, Inc. (0001636422) (Filer)

      5/9/25 4:45:02 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Health Catalyst, Inc. (0001636422) (Filer)

      5/7/25 4:08:03 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Amendment: SEC Form 10-K/A filed by Health Catalyst Inc

      10-K/A - Health Catalyst, Inc. (0001636422) (Filer)

      4/30/25 4:32:35 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology

    $HCAT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Health Catalyst Reports First Quarter 2025 Results

      SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025. "For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly guidance on each metric," said Dan Burton, CEO of Health Catalyst. "Additionally, we are happy to share that we added 10 net new Platform Clients in Q1 2025. This is especially encouraging given that Q1 is typically a quieter bo

      5/7/25 4:03:00 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery Organizations

      Health Catalyst's Improvement Expertise Built on Microsoft Azure and Azure AI Foundry to Drive Reliable Insight and Sustained Outcomes for Care Providers SALT LAKE CITY, April 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a strategic partnership with Microsoft to help healthcare organizations accelerate operational, clinical, and financial performance through AI-driven innovation. The collaboration further builds on Health Catal

      4/29/25 8:30:00 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025

      SALT LAKE CITY, April 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2025 operating results on Wednesday, May 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ125." A live audio webcast will be available online at https://ir.healthcatalyst.com/. A

      4/17/25 8:00:00 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology

    $HCAT
    Financials

    Live finance-specific insights

    See more

    $HCAT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $HCAT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Health Catalyst Reports First Quarter 2025 Results

      SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025. "For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly guidance on each metric," said Dan Burton, CEO of Health Catalyst. "Additionally, we are happy to share that we added 10 net new Platform Clients in Q1 2025. This is especially encouraging given that Q1 is typically a quieter bo

      5/7/25 4:03:00 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025

      SALT LAKE CITY, April 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2025 operating results on Wednesday, May 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ125." A live audio webcast will be available online at https://ir.healthcatalyst.com/. A

      4/17/25 8:00:00 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst Reports Fourth Quarter and Year End 2024 Results

      SALT LAKE CITY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2024. "For the full year 2024, I am pleased to share that we achieved strong performance across our business, including total revenue of $307 million and Adjusted EBITDA of $26 million. Additionally, I am encouraged with our Technology segment, which had revenue of $195 million for full-year 2024 and $52 million for the fourth quarter of 2024, which represents 10% growth year-over-year. I am pleased with this pr

      2/26/25 4:03:00 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Chief Operating Officer Lesueur Daniel sold $21,331 worth of shares (5,209 units at $4.10), decreasing direct ownership by 2% to 205,832 units (SEC Form 4)

      4 - Health Catalyst, Inc. (0001636422) (Issuer)

      5/7/25 6:15:45 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Chief Operating Officer Lesueur Daniel sold $21,604 worth of shares (5,209 units at $4.15), decreasing direct ownership by 2% to 211,041 units (SEC Form 4)

      4 - Health Catalyst, Inc. (0001636422) (Issuer)

      4/7/25 7:02:12 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • General Counsel Landry Benjamin sold $62,860 worth of shares (13,827 units at $4.55), decreasing direct ownership by 8% to 160,437 units (SEC Form 4)

      4 - Health Catalyst, Inc. (0001636422) (Issuer)

      3/10/25 4:16:01 PM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst downgraded by Evercore ISI

      Evercore ISI downgraded Health Catalyst from Outperform to In-line

      4/9/25 8:35:36 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst upgraded by KeyBanc Capital Markets with a new price target

      KeyBanc Capital Markets upgraded Health Catalyst from Sector Weight to Overweight and set a new price target of $9.00

      1/8/25 7:52:29 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst downgraded by KeyBanc Capital Markets

      KeyBanc Capital Markets downgraded Health Catalyst from Overweight to Sector Weight

      4/10/24 7:47:26 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology

    $HCAT
    Leadership Updates

    Live Leadership Updates

    See more
    • Ardent Health Appoints Robert DeMichiei to Board of Directors

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U

      4/3/25 5:27:00 PM ET
      $AP
      $ARDT
      $HCAT
      $WAY
      Fluid Controls
      Industrials
      Hospital/Nursing Management
      Health Care
    • Modern Health Welcomes Adam Brown as Chief Financial Officer

      Strengthens Executive Team with Seasoned Healthcare Finance Leader Modern Health, a leading global workplace mental health platform, today announces the appointment of Adam Brown as Chief Financial Officer. With an extensive background in healthcare finance and operations, including significant experience scaling high-growth healthcare technology companies, Brown brings deep industry expertise to the company. "Adam is a valued addition to Modern Health's leadership team, and we are thrilled to welcome him on board. His impressive track record and deep understanding of both public and private markets strengthens our executive bench as we continue to execute our vision," said Gyre Renwick

      1/15/25 10:16:00 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology
    • Health Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare Services

      SALT LAKE CITY, Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has signed a definitive agreement to acquire Upfront Healthcare Services, Inc. ("Upfront"), a next-generation patient engagement platform provider. Health Catalyst anticipates the acquisition will close in the first quarter of 2025.Upfront provides a market-leading patient activation and engagement platform and a proprietary strategic marketing analytics and content personalization solution for healthcare enterprises. Upfront's automated patient acquisition and retention solu

      1/13/25 8:00:00 AM ET
      $HCAT
      Computer Software: Programming Data Processing
      Technology